Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension
- 30 November 1996
- journal article
- Published by Elsevier in Survey of Ophthalmology
- Vol. 41, S27-S37
- https://doi.org/10.1016/s0039-6257(96)82029-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Long term effect of apraclonidine.British Journal of Ophthalmology, 1995
- Analogs of UK 14,304: Structural features responsible for α2 adrenoceptor activityBioorganic & Medicinal Chemistry Letters, 1995
- Clinical Experience With the Long-term Use of 1% ApraclonidineArchives of Ophthalmology (1950), 1995
- Side Effects of ??-Adrenergic AgonistsJournal of Glaucoma, 1995
- The potential of ??2-adrenergic agonists in the medical treatment of glaucomaCurrent Opinion in Opthalmology, 1994
- Analogs of UK 14,304 as α2-adrenoceptor agonists. Twist and agent polarity as design elements.Bioorganic & Medicinal Chemistry Letters, 1994
- Comparison of Apraclonidine and Timolol in Chronic Open-angle GlaucomaOphthalmology, 1993
- UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypesEuropean Journal of Pharmacology, 1981
- The Effect of Topical Clonidine on Intraocular PressureArchives of Ophthalmology (1950), 1981
- Average Partial Association in Three-Way Contingency Tables: A Review and Discussion of Alternative TestsInternational Statistical Review, 1978